(PresseBox) ( Wangs,)
Straub Medical AG, a privately held Swiss company, announces that it has approved a full acquisition by Becton, Dickinson and Company (BD). The acquisition was completed on April 20, 2020. Straub Medical AG is headquartered in Wangs, where it manufactures, develops and sells medical devices for the treatment of arterial and venous diseases that are used worldwide by vascular surgeons and interventional specialists in radiology, angiology and surgery. This acquisition gives BD access to the world’s leading products and innovative technologies from Straub Medical, and to the valuable experience and expertise of its employees.
Gido Karges, CEO of Straub Medical, explains: “BD is the ideal strategic addition to Straub Medical. With its complementary product portfolio and established global sales channels, BD offers treatment solutions for vascular specialists around the world To advance the world of health. ”
“With our extensive expertise in endovascular technologies and our strong global infrastructure, BD is the right company to offer Straub Medical products worldwide as an important building block of our modern treatment solutions,” said Steve Williamson, president of BD’s Peripheral Intervention business. “We are committed to improving the quality of life for the more than 200 million people worldwide who are affected by occlusive diseases of the peripheral arteries. We are also committed to providing more instruments for treating venous diseases. The acquisition of Straub Medical makes it possible to help physicians worldwide treat even more affected patients. ”
All employees in all branches are taken over by BD. BD looks forward to the continued rapid growth of the company, beginning with BD’s distribution of the products in the US market.
About BD
BD (Becton, Dickinson and Company) is one of the largest international medical technology companies committed to advancing the world of health through improvements in medical research, diagnostics, patient care and care. The company supports medical professionals in their day-to-day work – with innovative technologies, services and concepts that help to improve patient care and everyday clinical processes. 65,000 BD employees worldwide dedicate themselves to the task of optimizing treatment results, making clinical processes safer and more efficient, enabling laboratory specialists to Diagnosing diseases faster and more accurately and supporting researchers in developing new diagnostic and treatment options. BD is represented in almost every country in the world and maintains partnerships with international organizations to meet the most pressing challenges in health care for people around the world. By working closely with its customers, BD is helping to achieve better clinical results, lower costs, improve clinical and laboratory efficiency, improve patient and user safety, and expand access to healthcare. to address the most pressing health care challenges facing people around the world. By working closely with its customers, BD is helping to achieve better clinical results, lower costs, improve clinical and laboratory efficiency, improve patient and user safety, and expand access to healthcare. to address the most pressing health care challenges facing people around the world. By working closely with its customers, BD is helping to achieve better clinical results, lower costs, improve clinical and laboratory efficiency, improve patient and user safety, and expand access to healthcare.
For more information about BD, please visit bd.com.
